Delivery Order SPE2DR25D2010-SPE2DR26F4ZBU
- Not listed
- The Defense Logistics Agency awarded a $14,575.89 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on November 24, 2025, with completion expected by November 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $42,952.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on December 8, 2025, with final completion scheduled for December 9, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $15,872.15 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 15, 2025, with completion expected by September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,499.28 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,107.17 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on June 2, 2025, with an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $70,061.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, where the products will...
- The Defense Logistics Agency awarded a delivery order valued at $3,258.15 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,753.37 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-pack units) with an ultimate completion date of October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $4,994.46 delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This firm fixed-price contract, which is a child order under AmerisourceBergen's larger indefinite delivery contract with DLA, represents a competitively awarded, non-set-aside procurement with an ultimate completion date of November 25, 2025. The pharmaceutical product will be delivered to the company's corporate...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4ZBUDelivery Order
The Defense Logistics Agency (DLA) awarded a $31,949.98 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 1, 2025, with completion scheduled for December 2, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a critical pharmaceutical vendor for federal medical procurement, supplying medications and medical supplies across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, and other government entities worldwide. The company's extensive federal contract portfolio demonstrates its established capability to meet demanding procurement requirements through competitive bidding and reliable delivery of brand-name and generic pharmaceutical products essential to military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.9k | 11/30/25 |